Search results
Results from the WOW.Com Content Network
Amblyopia. Anisometropia is a condition in which a person's eyes have substantially differing refractive power. [ 1] Generally, a difference in power of one diopter (1D) is the threshold for diagnosis of the condition. [ 2][ 3] Patients may have up to 3D of anisometropia before the condition becomes clinically significant due to headache, eye ...
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD.Approaches that have been evaluated in the management of ADHD symptoms include FDA-approved pharmacologic treatment and other pharmaceutical agents, psychological or behavioral approaches, combined pharmacological and behavioral approaches, cognitive training ...
MDMA “has been shown to be safe and effective in the right conditions,” says Sunil Aggarwal, M.D., Ph.D., a physician in Seattle, Washington, who had been hoping to soon prescribe the drug to ...
Researchers have found that molecules and microorganisms both inside and outside our bodies are going through dramatic changes, first at about age 44 and then again when we hit 60. Those ...
The U.S. Food and Drug Administration (FDA) has approved a new drug for certain adult patients with endometrial cancer. Jemperli (dostarlimab-gxly) — made by British pharmaceutical company GSK ...
Stimulants are some of the most effective medications available for the treatment of ADHD. Seven different formulations of stimulants have been approved by the U.S. Food and Drug Administration (FDA) for the treatment of ADHD: four amphetamine-based formulations, two methylphenidate-based formulations, and dextromethamphetamine hydrochloride.
Treatment of resistant strains became increasingly dependent on this class of drugs. The cost of artemisinins limits their use in the developing world. [ 196 ] Malaria strains found on the Cambodia–Thailand border are resistant to combination therapies that include artemisinins, and may, therefore, be untreatable. [ 197 ]
August 2, 2024 at 1:20 PM. By Mariam Sunny. (Reuters) -The U.S. Food and Drug Administration said on Friday it has approved Adaptimmune's first-of-its-kind treatment for a rare type of cancer in ...